Introduction: The prostate cancer antigen 3 (PCA3) score has been the first urine assay to
obtain the Food and Drug Administration approval for guiding decisions regarding additional …

The study aimed at evaluating the performance of urinary exosomal prostate‐specific
antigen (UE‐PSA) to predict the results of initial prostate biopsies and discriminate clinically …

Background: The diagnostic value and suitability of prostate cancer antigen 3 (PCA3) for the
detection of prostate cancer (PCa) have been inconsistent in previous studies. Thus, the aim …

Prostate cancer is one of the leading causes of death despite an astoundingly high survival
rate for localized tumors. Though prostate specific antigen (PSA) test, performed in …

Screening of prostatic cancer is a matter of debate among uro-oncologist. With many new
screening modalities like prostatic health index (PHI), 4K testing the role of screening has …

Purpose To explore the diagnostic accuracy of prostate cancer antigen 3 (PCA3) test for the
diagnosis of prostate cancer in this systematic review and meta-analysis. Patients and …

Objectives To know the necessary information to reproduce the results found in the literature
on active surveillance (AS) in prostate cancer (PCa) in our own center so that the information …

Objectives PCA3 performance as a single second line biomarker is compared to the
European Randomized Study of Screening for Prostate Cancer risk calculator model 3 …

Objetivos Conocer la información necesaria para reproducir los resultados de la literatura
en vigilancia activa (VA) en cáncer de próstata (CaP) en nuestro propio centro, de tal forma …

El cáncer de próstata (CaP) es la segunda causa de muerte relacionada con cáncer en el
varón en el mundo occidental. Para reducir la mortalidad y aumentar la tasa de …